Live feed07:00:00·1965dPRReleasevia QuantisnowTaysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program, Now Known as TSHA-120, for the Treatment of Giant Axonal Neuropathy, a Rare and Severe Neurodegenerative DiseaseByQuantisnow·Wall Street's wire, on your screen.TSHA· Taysha Gene Therapies Inc.Health Care
